✦ LIBER ✦

Safety and tolerability of tegaserod in patients treated for chronic constipation (CC): A 12-week, double-blind, placebo-controlled multicenter study performed in the americas

✍ Scribed by Wald, Arnold; Johanson, John; Tougas, Gervais; Chey, William; Novick, James; Lembo, Anthony; Fordham, Fiona; Guella, Mary; Nault, Brigitte

Book ID: 121967360
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 231 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)82902-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: the efficacy, impact on

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12-week, randomized, double-blind, placebo-controlled study

✍ E. M. M. QUIGLEY; L. VANDEPLASSCHE; R. KERSTENS; J. AUSMA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Efficacy and tolerability of valdecoxib

Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study

✍ Allan Gibofsky; Jude Rodrigues; Justus Fiechtner; Manuela Berger; Sharon Pan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 187 KB

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED,

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND TOLERANCE OF REGADENOSON IN PATIENTS WITH RENAL IMPAIRMENT

✍ Karthikeyan Ananthasubramaniam; Robert Weiss; Barbara Klauke; Bruce McNutt; Kath 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB

A phase 2, double-blind, randomized, pla

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

✍ Webster, Lynn; Dhar, Sunita; Eldon, Michael; Masuoka, Lorianne; Lappalainen, Jaa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 320 KB

286 Efficacy and Safety of Once Daily Li

286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

✍ Anthony Lembo; Harvey Schneier; Bernard J. Lavins; Steven J. Shiff; James E. Mac 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Randomised, placebo-controlled, double-b

Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation

✍ R. Wulkow; J.-M. Vix; C. Schuijt; H. Peil; M. A. Kamm; C. Jordan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB